Results 111 to 120 of about 2,005,926 (345)

Gene frequency and distribution of human platelet antigen-1 to −6, −10, −15, and −21 of platelets donors in Wuhan, China

Global Medical Genetics
Background: In this study, the frequency of human platelet antigen (HPA) alleles and genotypes of platelet donors in Wuhan was evaluated and differences in HPA distribution between Wuhan and other regions in China were compared. Study Design and Methods:
Zhen Qu, Wangxia Li, Yuanyan Zhu, Xue Zheng, Mingdi He, Gang Shen, Anyu Bao   +6 more
doaj  

Leukoreduced blood components: Advantages and strategies for its implementation in developing countries

Asian Journal of Transfusion Science, 2010
Removal of leucocytes from various blood products has been shown to minimize Febrile nonhemolytic transfusion reactions, HLA alloimmunization, platelet refractoriness in multitransfused patients and prevention of transmission of leukotropic viruses such ...
Sharma R, Marwaha Neelam
doaj  

Financial cost of whole blood and blood component disposals in a Brazilian coordinating blood center

Revista Gaúcha de Enfermagem
Objective: To describe the reasons for the disposal of blood in the coordinating blood center of the State of Paraná and to estimate the financial costs resulting from potentially avoidable discards.
Magali Zimmermann Covo, Elaine Drehmer de Almeida Cruz, Aline Batista Maurício, Josemar Batista, Liana Andrade Labres de Souza   +4 more
doaj   +2 more sources

Transfusion support in preterm neonates <1500 g and/or <32 weeks in a tertiary care center: A descriptive study

Asian Journal of Transfusion Science, 2018
Background: Lack of recent studies focusing on indications, pattern, and benefits of transfusions in low birth weight (B.Wt) and low gestational age (GA) preterm neonates prompted us to undertake this study.
R A Shanmugha Priya, R Krishnamoorthy, Vinod Kumar Panicker, Binu Ninan   +3 more
doaj   +1 more source

Towards an Innovative Sensor in Smart Capsule for Aerial Drones for Blood and Blood Component Delivery. [PDF]

Micromachines (Basel), 2022
Liu R, Pitruzzello G, Rosa M, Battisti A, Cerri C, Tortora G.   +5 more
europepmc   +1 more source

Tissue components of the domestic fowl. 2. Blood urea [PDF]

, 1957
David Bell
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients

Journal of Emergencies, Trauma and Shock, 2018
Background: Uncontrolled hemorrhage still remains a major cause of trauma-associated mortality. The events resulting in acute traumatic coagulopathy, particularly hypofibrinogenemia, make control of bleeding difficult.
Shahram Paydar, Behnam Dalfardi, Zahra Shayan, Leila Shayan, Jalal Saem, Shahram Bolandparvaz   +5 more
doaj   +1 more source

Rotational ThromboElastometry-guided blood component administration versus standard of care in patients with Cirrhosis and coagulopathy undergoing Invasive ProcEdures (RECIPE): study protocol for a randomised controlled trial. [PDF]

Trials, 2023
Janko N, Majeed A, Kemp W, Hogan C, Nandurkar H, Roberts SK.   +5 more
europepmc   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source